Table 3 Comparison in bivariate analysis of potential risk factors influencing the risk of presenting with at least one flare during the first 6 months of follow up of patients with all data available

Number of patients

23

13

/

DECT MSU volume knees (cm³)

0.6 ± 1.2

1.1 ± 1.6

0.24

DECT MSU volume feet (cm³)

0.9 ± 0.8

2.1 ± 1.9

0.05

Serum urate change between M0 and M6 (mg/dL)

1.51 ± 2.03

1.50 ± 2.48

0.88

Number of joints with the US double contour sign at M0 (/6)

2.5 ± 0.9

2.9 ± 1.5

0.67

Declared number of flares over the past year

3 ± 4.4

4.2 ± 6.2

0.41

Ongoing flare prophylaxis at M6

11 (47.8%)

6 (46.2%)

1

Ongoing urate lowering therapy at M0

13 (56.5%)

6 (46.2%)

0.8